CSIMarket
 


Biocryst Pharmaceuticals Inc   (BCRX)
Other Ticker:  
 

Biocryst Pharmaceuticals Inc 's Leverage Ratio

BCRX's quarterly Leverage Ratio and Total Liabilities, Equity growth


In IV Quarter 2023 Biocryst Pharmaceuticals Inc had stockholder deficit.

Within Biotechnology & Pharmaceuticals industry Biocryst Pharmaceuticals Inc achieved the lowest Leverage Ratio in the forth quarter 2023. While total ranking remained the same in the forth quarter 2023 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are BCRX Customers?
What are BCRX´s Total Liabilities?


BCRX Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Liabilities Change 34.43 % 27.25 % -46.58 % -54.09 % -51.5 %
Leverage Ratio MRQ - - - - -
BCRX's Total Ranking # # # # #
Seq. Equity Change - - - - -
Seq. Total Liabilities Change 16.58 % 0.54 % 21.72 % -5.77 % 10.35 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Biocryst Pharmaceuticals Inc 's Equity $ -456 Millions Visit BCRX's Balance sheet
Biocryst Pharmaceuticals Inc 's Total Liabilities $ 453 Millions Visit BCRX's Balance sheet
Source of BCRX's Sales Visit BCRX's Sales by Geography


Cumulative Biocryst Pharmaceuticals Inc 's Leverage Ratio

BCRX's Leverage Ratio for the trailling 12 Months

BCRX Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth 34.43 % 27.25 % -46.58 % -54.09 % -51.5 %
Leverage Ratio TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth - - - - -
Seq. Total Liabilities TTM Growth 16.58 % 0.54 % 21.72 % -5.77 % 10.35 %


On the trailing twelve months basis During the 12 months period ending IV Quarter 2023 company had stockholder deficit.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry BCRX recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Leverage Ratio?
Who are BCRX Customers?
What are BCRX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity

Date modified: 2024-02-28T14:56:15+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com